Pomalidomide enhances CAR-T cell therapeutic efficacy and remodels immune microenvironment in lymphoid malignancies

Related articles

1. NKG2D-Based CAR-T Cells for Cancer Immunotherapy: Biological Rationale, Clinical Experience, and Current Challenges

   This article has 2 authors:

   1. Vitaly Chasov
   2. Albert Rizvanov

2. Construction of a Novel T Cell Subtype with Immunotherapeutic Value in Bladder Cancer and a Neural Network-Based Prognostic Model

   This article has 8 authors:

   1. Xiaoliang Dou
   2. Chaochao Cui
   3. Yaodong zhang
   4. Dali He
   5. Tianci Mao
   6. Tao Li
   7. Long Gao
   8. Jinhai Fan

3. Repurposing BH3 mimetics to deplete tumour-infiltrating regulatory T cells and enhance anti-tumour immunity in non-small cell lung cancer

   This article has 9 authors:

   1. Marie Liesse Asselin-labat
   2. Eddy Yao
   3. Clare Weeden
   4. Tianwei Chen
   5. Claire Marceaux
   6. Lucille Rankin
   7. Dan Batey
   8. Charis Teh
   9. Daniel Gray